Literature DB >> 125073

Acute myelofibrosis in children with Down's syndrome.

D I Evans.   

Abstract

Two boys with Down's syndrome, recognized at birth, developed acute myelogibrosis at the ages of 19 and 21 months. The disorder presented with anaemia and splenomegaly, and clinically resembled acute leukaemia, but bone marrow histology showed a bizarre pattern with generalized fibrosis, markedly increased reticulin, large reticulum cells, and giant cells resembling megakaryocytes. The children survived 6 and 11 months from diagnosis. A third case is quoted (Hillman and Forrester, 1968) which was also studied at this hospital; the features of all 3 cases are similar. There appears to be an increased incidence of acute myelofibrosis in children with Down's syndrome, which may be a further example of the instability of the haemopoietic system in the disease. In children with Down's syndrome and unusual leukaemia-like illness, histological examination of the bone marrow may be diagnostic.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 125073      PMCID: PMC1544537          DOI: 10.1136/adc.50.6.458

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  20 in total

1.  MALIGNANT MYELOSCLEROSIS.

Authors:  S M LEWIS; L SZUR
Journal:  Br Med J       Date:  1963-08-24

2.  RETICULIN FIBROSIS AND BONE INFARCTION IN ACUTE LEUKEMIA. IMPLICATIONS FOR PROGNOSIS.

Authors:  D W KUNDEL; G BRECHER; G P BODEY; G M BRITTIN
Journal:  Blood       Date:  1964-04       Impact factor: 22.113

3.  [Osteomyelosclerosis in father and daughter].

Authors:  A DECASTELLO
Journal:  Wien Klin Wochenschr       Date:  1954-09-03       Impact factor: 1.704

4.  Ineffective regulation of granulopoiesis masquerading as congenital leukemia in a mongoloid child.

Authors:  J D ROSS; W C MOLONEY; J F DESFORGES
Journal:  J Pediatr       Date:  1963-07       Impact factor: 4.406

5.  [A case of megakaryocytic myelosis in a child].

Authors:  T FUJINAMI; T SUGIYAMA; H TANKAWA; Y UESUGI
Journal:  Shonika Kiyo       Date:  1961 May-Jun

6.  Simultaneous occurrence of mongolism and leukemia; report of a nationwide survey.

Authors:  W KRIVIT; R A GOOD
Journal:  AMA J Dis Child       Date:  1957-09

7.  The myeloproliferative syndrome in children.

Authors:  H S ROSENBERG; F M TAYLOR
Journal:  J Pediatr       Date:  1958-04       Impact factor: 4.406

8.  Some speculations on the myeloproliferative syndromes.

Authors:  W DAMESHEK
Journal:  Blood       Date:  1951-04       Impact factor: 22.113

9.  Hyperblastic response to dilute P.H.A. in Down's syndrome.

Authors:  H Hayakawa; I Matsui; M Higurashi; N Kobayashi
Journal:  Lancet       Date:  1968-01-13       Impact factor: 79.321

10.  [Familial myeloid splenomegaly].

Authors:  J Bernard; M Seligmann; C Loirat; J Chassigneux; A Basch; A Gueudet
Journal:  Nouv Rev Fr Hematol       Date:  1967 Jul-Aug
View more
  6 in total

1.  Chronic Childhood Idiopathic Myelofibrosis in Down's Syndrome: A Case Report.

Authors:  Smita Singh; Sunita Sharma; Narender Tejwani; Jagdish Chandra
Journal:  Indian J Hematol Blood Transfus       Date:  2011-10-18       Impact factor: 0.900

2.  Dicentric chromosome in the bone marrow of a child with megakaryoblastic leukaemia and Down's syndrome.

Authors:  A O Wilkie; C Kitchen; A Oakhill; R T Howell; P J Berry
Journal:  J Clin Pathol       Date:  1988-04       Impact factor: 3.411

3.  Florid radiological appearance of megakaryoblastic leukaemia--an aid to earlier diagnosis.

Authors:  A Moody; E Simpson; D Shaw
Journal:  Pediatr Radiol       Date:  1989

4.  Leukaemia and transient leukaemia in Down syndrome.

Authors:  L Iselius; P Jacobs; N Morton
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

5.  Familial myelofibrosis.

Authors:  C A Sieff; P Malleson
Journal:  Arch Dis Child       Date:  1980-11       Impact factor: 3.791

6.  Down syndrome and leukemia: unusual clinical aspects and unexpected methotrexate sensitivity.

Authors:  M Peeters; A Poon
Journal:  Eur J Pediatr       Date:  1987-07       Impact factor: 3.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.